| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155206 Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers |
| 06/18/2009 | CA2707679A1 Agent for treating ulcer |
| 06/17/2009 | EP2070544A2 Means of withdrawal from smoking |
| 06/17/2009 | EP2070519A1 Preparation for the prevention and/or treatment of dementia syndromes |
| 06/17/2009 | EP2068952A2 Hydroxyapatite tissue filler and its preparation and use |
| 06/17/2009 | EP2068895A1 Selective chemokine modulation |
| 06/17/2009 | EP2068894A1 Use of cis-rhenium (iii) diadamantate compounds for potentiating the antitumoral activity of platinium complexes |
| 06/17/2009 | EP2068893A2 Liquid chalcogenide compositions and methods of manufacturing and using the same |
| 06/17/2009 | EP2068892A1 Wound healing compositions |
| 06/17/2009 | EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 06/17/2009 | EP1004310B1 Gelled composition |
| 06/17/2009 | CN101455678A Paste for treating epidemic parotitis |
| 06/17/2009 | CN101455677A Combination method of perneiras treatment medicine |
| 06/17/2009 | CN100500162C Anti-coronavirus agent |
| 06/16/2009 | US7547723 Comprehensive pharmacologic therapy for treatment of a dysfunction |
| 06/16/2009 | US7547716 Sulfonamide derivatives |
| 06/16/2009 | US7547456 A Feverfew plant extract and a cosmetically- acceptable topical carrier, free of parthenolide for regulating the firmness, tone, texture of skin and also regulating wrinkles in the skin |
| 06/11/2009 | WO2009072779A1 Composition comprising sodium meta-arsenite for treatment of hepatitis c |
| 06/11/2009 | WO2009072120A1 Use of zinc in combination with chemotherapy for treating cancer |
| 06/11/2009 | WO2003011214A3 Novel methods and formulations for administration of active agents |
| 06/11/2009 | US20090149478 Novel combination anticancer agents |
| 06/11/2009 | US20090148566 Carbohydrate And Electrolyte Replacement Composition |
| 06/11/2009 | US20090148541 Compositions and methods for the treatment of seborrhea |
| 06/11/2009 | US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148538 Use of adsorbent carbon microspheres to treat pouchitis |
| 06/11/2009 | US20090148502 Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding |
| 06/11/2009 | US20090148489 Bioabsorbable material |
| 06/11/2009 | US20090148433 Metallo-protein and tocotrienol (mp-t3) compositions and uses thereof |
| 06/10/2009 | EP2067478A1 Agent for prevention or treatment of blood glucose level elevation |
| 06/10/2009 | EP2066680A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 06/10/2009 | EP2066311A2 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| 06/10/2009 | EP1890554A4 Calcium fortification of bread dough |
| 06/10/2009 | EP1085900B1 Use of erythropoietin for the treatment of primary haemochromatoses |
| 06/10/2009 | DE10143146B4 Antiarthrotische Zubereitung und deren Verwendung Antiarthrotische preparation and their use |
| 06/10/2009 | CN101450077A Preparation method of external natural aluminosilicate emergency life-saving hemostatic |
| 06/10/2009 | CN101450076A Ochre forging method |
| 06/10/2009 | CN101450075A Hydroxyethyl starch 130/0.4 sodium chloride injection and preparation method and use thereof |
| 06/10/2009 | CN101450074A Composition capable of greatly improving gastrointestinal tract function and preventing and treating astriction |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100496596C Improved Chinese medicinal paste for arthralgia and its preparation |
| 06/10/2009 | CN100496510C Injection for necrotizing therapy for hemorrhoids |
| 06/10/2009 | CN100496509C Carbon monoxide product and its uses for treating ileus |
| 06/10/2009 | CN100496485C Antineoplastic combinations |
| 06/10/2009 | CN100496480C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 06/09/2009 | US7544301 Citrate-based dialysate chemical formulations |
| 06/09/2009 | CA2481005C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 06/09/2009 | CA2388939C Therapeutic treatments for blood cell deficiencies |
| 06/09/2009 | CA2337772C Skin and tissue care and/or treatment agent |
| 06/04/2009 | WO2009070547A1 Cancer treatment using cox-2 inhibitor and antimetabolite combinations |
| 06/04/2009 | WO2009052295A3 Cerium oxide nanoparticles for treatment and prevention of alzheimer's disease, parkinson's disease, and disorders associated with free radical production and/or mitochondrial dysfunction |
| 06/04/2009 | WO2008155589A3 Biocide capsules, preparation comprising them and sanitary pad comprising the preparation |
| 06/04/2009 | US20090143464 Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent |
| 06/04/2009 | US20090142416 Methods for the treatment of HIV and other viruses |
| 06/04/2009 | US20090142415 Selective resonance of chemical structures |
| 06/04/2009 | US20090142413 Targeted short-lived drug delivery |
| 06/04/2009 | US20090142412 Skin Care Cosmetic Cream/Scrub Product |
| 06/04/2009 | US20090142411 Composition and Device Comprising an Inorganic Component (Metal Compound) for Coagulation of Protein-Containing Fluids |
| 06/04/2009 | US20090142410 Nutritional composition and method for increasing creatine uptake and retention in skeletal muscle, increasing muscle mass and strength, increasing exercise capacity and for aiding recovery following exercise |
| 06/04/2009 | US20090142394 Gastric Antacid |
| 06/04/2009 | US20090142385 Compositions for treating bone defects |
| 06/04/2009 | US20090142314 Maternal supplement |
| 06/04/2009 | DE112007001469T5 Collagensynthese-Promotor, der Zink als aktiven Bestandteil enthält Contains collagen synthesis promoter, the zinc as an active ingredient |
| 06/04/2009 | CA2853152A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 06/04/2009 | CA2707153A1 Cancer treatment using cox-2 inhibitor and antimetabolite combinations |
| 06/03/2009 | EP2063901A2 Novel triclosan salts |
| 06/03/2009 | EP2063859A1 Cosmetic composition for the treatment of skin and methods thereof |
| 06/03/2009 | EP1959972A4 Method of treating open wounds using hypochlorous acid |
| 06/03/2009 | EP0928184B1 Anti-caries oral compositions |
| 06/03/2009 | CN101448509A Prevention and treatment of osteochondrosis in animals and humans |
| 06/03/2009 | CN101444529A Formula process of reinforced micro-element paste |
| 06/03/2009 | CN100494398C Method of determining glutachione-S-transferase pi expression |
| 06/03/2009 | CN100493520C Selenium-rich lactobacillus preparation and its production process and application |
| 06/02/2009 | US7541329 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/02/2009 | US7541052 Hypertonic solutions and method of treatment |
| 06/02/2009 | CA2410160C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 06/02/2009 | CA2309104C Metal/thiol biocides |
| 06/02/2009 | CA2304950C Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 06/02/2009 | CA2158475C Composition and method for reducing toxicity of biologically-active factors |
| 05/28/2009 | WO2009067067A1 Method and means for obtaining bronchorelaxation |
| 05/28/2009 | WO2009066766A1 Process for producing hydrogen-containing drinking water |
| 05/28/2009 | WO2009065947A2 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids |
| 05/28/2009 | WO2008003050A3 Gallium nitrate formulations |
| 05/28/2009 | WO2007106633A3 Perfluorochemical treatment process and apparatus |
| 05/28/2009 | US20090137619 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent |
| 05/28/2009 | US20090137536 Method for treating and preventing hyperparathyroidism |
| 05/28/2009 | US20090136961 Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancer |
| 05/28/2009 | US20090136742 Ag-containing solution, antibacterial resin composition comprising the solution and antibacterial resin coated steel plate |
| 05/28/2009 | US20090136599 Homeopathic composition and kit therefore |
| 05/28/2009 | US20090136598 Compositions for the Treatment and Prevention of Eyelid Swelling |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136594 Functionalization of Micro-And Nano Particles for Selective Attachment to Calcium Biomineral Surfaces |
| 05/28/2009 | US20090136593 Mazindol combination in the treatment of attention deficit/hyperactivity |
| 05/28/2009 | US20090136592 Vitamin preparation |
| 05/28/2009 | US20090136591 Metallothionein as an early biomarker for death secondary to septic shock and as a novel therapeutic target for septic shock |
| 05/28/2009 | US20090136590 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 05/28/2009 | US20090136588 Methods For Altering Food Intake, Modifying Nutrient Digestibility and Altering Stool Quality and/or Stool Frequency |
| 05/28/2009 | US20090136580 PREFERENTIAL KILLING OF CANCER CELLS AND ACTIVATED HUMAN T CELLS USING ZnO NANOPARTICLES |
| 05/28/2009 | US20090136539 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 05/28/2009 | US20090136410 Stabilization and ionic triggering of nitric oxide release |